Volume 70, Issue 1, Pages (July 2016)

Slides:

Advertisements

Similar presentations

Volume 64, Issue 5, Pages (November 2013)

Advertisements

Volume 61, Issue 5, Pages (May 2012)

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,

The PSA Era is not Over for Prostate Cancer

Volume 57, Issue 1, Pages (January 2010)

Volume 50, Issue 1, Pages (July 2006)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 4, Issue 5, Pages (September 2017)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 69, Issue 5, Pages (May 2016)

Volume 60, Issue 5, Pages (November 2011)

Volume 61, Issue 5, Pages (May 2012)

Volume 51, Issue 6, Pages (June 2007)

Volume 74, Issue 2, Pages (August 2018)

Volume 54, Issue 4, Pages (October 2008)

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.

Volume 53, Issue 5, Pages (May 2008)

Volume 66, Issue 3, Pages (September 2014)

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Volume 64, Issue 5, Pages (November 2013)

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 54, Issue 4, Pages (October 2008)

The Potential of MicroRNAs as Prostate Cancer Biomarkers

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 71, Issue 5, Pages (May 2017)

Volume 70, Issue 5, Pages (November 2016)

Volume 73, Issue 4, Pages (April 2018)

Laurent Boccon-Gibod European Urology Supplements

Volume 73, Issue 2, Pages (February 2018)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,

Volume 58, Issue 1, Pages 1-7 (July 2010)

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Volume 68, Issue 6, Pages (December 2015)

Volume 62, Issue 6, Pages (December 2012)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Prostate Cancer Nomograms: An Update

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer Amar U. Kishan, Rahul.

Volume 59, Issue 4, Pages (April 2011)

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Volume 54, Issue 1, Pages (July 2008)

Volume 53, Issue 6, Pages (June 2008)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 70, Issue 1, Pages 161-175 (July 2016) New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature Laura Evangelista, Alberto Briganti, Stefano Fanti, Stephen Joniau, Sven Reske, Riccardo Schiavina, Christian Stief, George N. Thalmann, Maria Picchio European Urology Volume 70, Issue 1, Pages 161-175 (July 2016) DOI: 10.1016/j.eururo.2016.01.029 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Flow of information through the different phases of the systematic review. a Only trials. b Filters: clinical trials/comparative study/controlled clinical trial/ evaluation studies/observational studies/humans/English language. c Articles/English language. European Urology 2016 70, 161-175DOI: (10.1016/j.eururo.2016.01.029) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Flow-chart of the diagnostic management of prostate cancer patients. ADT=antiandrogen therapy; BRT=brachytherapy; CT=chemotherapy; EBRT=external beam radiotherapy; PSA=prostate specific antigen; PSMA=prostate specific membrane antigen; RP=radical prostatectomy; sLND=salvage lymphadenectomy. European Urology 2016 70, 161-175DOI: (10.1016/j.eururo.2016.01.029) Copyright © 2016 European Association of Urology Terms and Conditions